These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30009419)

  • 1. Redefine the role of range shifter in treating bilateral head and neck cancer in the era of Intensity Modulated Proton Therapy.
    Ding X; Li X; Qin A; Zhou J; Yan D; Chen P; Prakash C; Stevens C; Deraniyagala R; Kabolizadeh P
    J Appl Clin Med Phys; 2018 Sep; 19(5):749-755. PubMed ID: 30009419
    [No Abstract]   [Full Text] [Related]  

  • 2. Online adaption approaches for intensity modulated proton therapy for head and neck patients based on cone beam CTs and Monte Carlo simulations.
    Botas P; Kim J; Winey B; Paganetti H
    Phys Med Biol; 2018 Dec; 64(1):015004. PubMed ID: 30524097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
    Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
    Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GPU-accelerated and Monte Carlo-based intensity modulated proton therapy optimization system.
    Ma J; Beltran C; Seum Wan Chan Tseung H; Herman MG
    Med Phys; 2014 Dec; 41(12):121707. PubMed ID: 25471954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-specific bolus for range shifter air gap reduction in intensity-modulated proton therapy of head-and-neck cancer studied with Monte Carlo based plan optimization.
    Michiels S; Barragán AM; Souris K; Poels K; Crijns W; Lee JA; Sterpin E; Nuyts S; Haustermans K; Depuydt T
    Radiother Oncol; 2018 Jul; 128(1):161-166. PubMed ID: 28951008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for a Compton camera for in vivo range verification of proton therapy.
    Rohling H; Priegnitz M; Schoene S; Schumann A; Enghardt W; Hueso-González F; Pausch G; Fiedler F
    Phys Med Biol; 2017 Apr; 62(7):2795-2811. PubMed ID: 28195562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of meta-analysis approach, comparing conventional radiotherapy, and proton beam therapy treating head and neck cancer.
    Shaikh F; Sodhi SK; Kale LM; Talib YA; Saleem HM
    J Cancer Res Ther; 2020; 16(3):594-599. PubMed ID: 32719273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective robust optimization: A new intensity-modulated proton therapy optimization strategy.
    Li Y; Niemela P; Liao L; Jiang S; Li H; Poenisch F; Zhu XR; Siljamaki S; Vanderstraeten R; Sahoo N; Gillin M; Zhang X
    Med Phys; 2015 Aug; 42(8):4840-7. PubMed ID: 26233211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual Field Simultaneous Optimization (IFSO) in spot scanning proton therapy of head and neck cancers.
    Anand A; Bues M; Gamez ME; Stefan C; Patel SH
    Med Dosim; 2019 Winter; 44(4):375-378. PubMed ID: 30871863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
    Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
    Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation.
    Landry G; Nijhuis R; Dedes G; Handrack J; Thieke C; Janssens G; Orban de Xivry J; Reiner M; Kamp F; Wilkens JJ; Paganelli C; Riboldi M; Baroni G; Ganswindt U; Belka C; Parodi K
    Med Phys; 2015 Mar; 42(3):1354-66. PubMed ID: 25735290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
    McDonald MW; Liu Y; Moore MG; Johnstone PA
    Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically Applicable Monte Carlo-based Biological Dose Optimization for the Treatment of Head and Neck Cancers With Spot-Scanning Proton Therapy.
    Wan Chan Tseung HS; Ma J; Kreofsky CR; Ma DJ; Beltran C
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1535-1543. PubMed ID: 27325476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLUKA particle therapy tool for Monte Carlo independent calculation of scanned proton and carbon ion beam therapy.
    Kozłowska WS; Böhlen TT; Cuccagna C; Ferrari A; Fracchiolla F; Magro G; Mairani A; Schwarz M; Vlachoudis V; Georg D
    Phys Med Biol; 2019 Mar; 64(7):075012. PubMed ID: 30695766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric feasibility of intensity modulated proton therapy in a transverse magnetic field of 1.5 T.
    Hartman J; Kontaxis C; Bol GH; Frank SJ; Lagendijk JJ; van Vulpen M; Raaymakers BW
    Phys Med Biol; 2015 Aug; 60(15):5955-69. PubMed ID: 26182957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
    Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
    Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer.
    Kurz C; Dedes G; Resch A; Reiner M; Ganswindt U; Nijhuis R; Thieke C; Belka C; Parodi K; Landry G
    Acta Oncol; 2015; 54(9):1651-7. PubMed ID: 26198654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the effect of air gap, depth, and range shifter thickness on TPS dosimetric accuracy in superficial PBS proton therapy.
    Shirey RJ; Wu HT
    J Appl Clin Med Phys; 2018 Jan; 19(1):164-173. PubMed ID: 29239528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Proton Therapy for the Management of Head and Neck Tumors.
    Trotter J; Lin A
    Surg Oncol Clin N Am; 2023 Jul; 32(3):587-598. PubMed ID: 37182994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.